Figure 4: Prognostic association of C1QTNF2 expression in a clinical HCV cirrhosis cohort. | Scientific Reports

Figure 4: Prognostic association of C1QTNF2 expression in a clinical HCV cirrhosis cohort.

From: Transcriptome-based repurposing of apigenin as a potential anti-fibrotic agent targeting hepatic stellate cells

Figure 4

(A) clinical cohort of 216 patients with compensated HCV-related cirrhosis6 was classified into C1QTNF2-high (n = 25) and low (n = 101) groups, and evaluated for association with cirrhosis progression, i.e., progression of Child-Pugh class21 from (A) to (B) or (C). P-value was calculated by log-rank test.

Back to article page